Cizzle Biotechnology (LON:CIZ) Issues Earnings Results

Cizzle Biotechnology (LON:CIZ) released its quarterly earnings results on Wednesday. The company reported GBX (0.08) earnings per share for the quarter, Digital Look Earnings reports.

Cizzle Biotechnology Stock Down 13.8%

CIZ opened at GBX 1.47 on Wednesday. The company has a 50 day moving average of GBX 1.67 and a two-hundred day moving average of GBX 2.23. The company has a market cap of £6.23 million, a P/E ratio of -8.62 and a beta of 0.02. Cizzle Biotechnology has a 52-week low of GBX 1.20 and a 52-week high of GBX 3.90.

Cizzle Biotechnology Company Profile

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.